SPRC-AB01: Phase II data

In a double-blind, placebo-controlled, U.S. Phase II trial in 58 post-surgical patients, the undisclosed higher dose of SPRC-AB01 antibiotic significantly reduced the signs and symptoms of chronic rhi...